MITCHEL SAYARE Insider Trading $ALT Altimmune, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MITCHEL SAYARE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MITCHEL SAYARE. MITCHEL SAYARE is Chief Executive Officer in IMMUNOGEN INC ($IMGN) and Director in PHARMATHENE, INC ($PIP).
MITCHEL SAYARE in Altimmune, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MITCHEL SAYARE: Director
Holdings: 26,363 shares
Current Value: $36,117
Latest Transaction: Oct 16 2020
$ALT Market Capitalization: $76.74M
$ALT Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MITCHEL SAYARE in Altimmune, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16 2020 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | M | 0.00 | 25,275 | 0 | 0 | |
| Oct 16 2020 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Buy | M | 0.00 | 25,275 | 0 | 26,363 | 1.1 K to 26.4 K (+2,323.07 %) |
| Sep 28 2020 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | A | 12.03 | 25,500 | 306,765 | 25,500 | |
| Jun 29 2020 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | A | 0.00 | 25,275 | 0 | 25,275 | |
| Jun 29 2020 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | A | 0.00 | 25,275 | 0 | 25,275 | |
| Jan 04 2019 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | A | 2.60 | 30,000 | 78,000 | 30,000 | |
| Apr 06 2018 | ALT | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | A | 0.95 | 35,000 | 33,250 | 35,000 | |
| Jan 03 2018 | PIP | Altimmune, Inc. | SAYARE MITCHEL | Director | Buy | P | 1.95 | 5,100 | 9,963 | 32,650 | 27.6 K to 32.7 K (+18.51 %) |
| Oct 17 2017 | PIP | Altimmune, Inc. | SAYARE MITCHEL | Director | Option Exercise | A | 2.50 | 20,000 | 50,000 | 20,000 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 2.20 | 20,000 | 44,000 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.69 | 20,000 | 33,800 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.81 | 18,361 | 33,233 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.51 | 20,000 | 30,200 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.64 | 20,000 | 32,800 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.45 | 20,000 | 29,000 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 2.67 | 52,139 | 139,211 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 2.67 | 60,000 | 160,200 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.60 | 20,000 | 32,000 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | M | 1.52 | 20,000 | 30,400 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 2.20 | 20,000 | 44,000 | 275,500 | 255.5 K to 275.5 K (+7.83 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.69 | 20,000 | 33,800 | 255,500 | 235.5 K to 255.5 K (+8.49 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.81 | 18,361 | 33,233 | 235,500 | 217.1 K to 235.5 K (+8.46 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.51 | 20,000 | 30,200 | 217,139 | 197.1 K to 217.1 K (+10.15 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.64 | 20,000 | 32,800 | 197,139 | 177.1 K to 197.1 K (+11.29 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.45 | 20,000 | 29,000 | 177,139 | 157.1 K to 177.1 K (+12.73 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 2.67 | 52,139 | 139,211 | 157,139 | 105 K to 157.1 K (+49.66 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 2.67 | 60,000 | 160,200 | 105,000 | 45 K to 105 K (+133.33 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.60 | 20,000 | 32,000 | 45,000 | 25 K to 45 K (+80.00 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Buy | M | 1.52 | 20,000 | 30,400 | 25,000 | 5 K to 25 K (+400.00 %) |
| Jun 03 2016 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Aug 04 2015 | PIP | PHARMATHENE, INC | SAYARE MITCHEL | Director | Option Exercise | A | 1.69 | 20,000 | 33,800 | 20,000 |
Page: 1